Could a 14-Day pill reverse stomach precancer?
Disease control
Recruiting now
This study tests whether the drug pyrvinium can reverse gastric intestinal metaplasia, a condition that raises the risk of stomach cancer. Thirty-two adults with high-risk features will take pyrvinium or a placebo for 14 days. Researchers will compare biopsies before and after tr…
Phase: PHASE2 • Sponsor: Katherine Garman • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC